5-methoxytryptophan has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Chou, CH; Ho, YL; Huang, CC; Hung, CS; Kuo, CC; Lee, CM; Lin, YH; Liu, LD; Wu, KK; Yeh, JF | 1 |
| Huang, WL; Liu, XW; Yang, CJ; Yang, J; Yang, Y; Zeng, P | 1 |
| Kuo, CC; Lin, YH; Wu, KK | 1 |
3 other study(ies) available for 5-methoxytryptophan and Heart Failure
| Article | Year |
|---|---|
5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
Topics: Aged; Biomarkers; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; ROC Curve; ST Elevation Myocardial Infarction; Time Factors; Tryptophan; Ventricular Remodeling | 2016 |
5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.
Topics: Heart Failure; Humans; Myocardial Infarction; Tryptophan | 2017 |
Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".
Topics: Heart Failure; Humans; Myocardial Infarction; Tryptophan | 2017 |